Celltrion Healthcare Presents Positive One-Year Data for the First High-Concentration, Low-Volume and Citrate-Free Biosimilar Adalimumab, YuflymaTM (CT-P17) in Patients With Rheumatoid Arthritis at EULAR 2021
One-year data have shown equivalent efficacy and comparable safety for Yuflyma™ (CT-P17) against reference adalimumab in patients with moderate-to-severe active...

El-Sayed projected to win Michigan Senate seat despite tightening race
Democrats seize Senate, flip Ohio governor as Ramaswamy loses and markets watch
Democrats win the House as Trump’s Republican Party pays the price
Axar Patel Dropped for India’s 5th T20I vs New Zealand After Historic T20 Double
Sony’s Black Friday PS5 sale dates are set, but console discounts remain patchy 













